Author: Sana Khochtali (Tunisia)
Co-authors: Khawla Fekih, Molka Khairallah, Olfa Beizig, Mohamed Damak, Bechir Jelliti, Moncef Khairallah
Purpose
To describe clinical profile, treatment modalities, and visual outcomes in 20 patients with sympathetic ophthalmia from a single referral center of uveitis.
Setting/Venue
Department of Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Methods
Retrospective review of the charts of 20 patients diagnosed with sympathetic ophthalmia.
Results
Mean age was 53.8 years (range, 15-78) with 12 male (60%) and 8 female patients. The most common inciting event was trauma (65%), followed by vitreoretinal surgery (20%). Mean initial best-corrected visual acuity (BCVA) of the sympathizing eye was 20/250 (range, 20/2000-20/20). Clinical findings included exudative retinal detachment in 12 eyes (60%), optic disc swelling in 17 eyes (85%), retinal striae in 8 eyes (40%), vitritis in 18 eyes (90%), and anterior chamber inflammation in 11 eyes (55%). Fluorescein angiography showed pinpoints in 11 eyes (55%), late dye pooling in 11 eyes (55%), and disc hyperfluorescence in 18 eyes (90%). OCT demonstrated exudative retinal detachment in 14 eyes (70%) and folds of the retinal pigment epithelium in 13 eyes (65%). Treatment modalities included systemic corticosteroids in 16 patients (80%), immunosuppressive therapy in 16 patients (80%), and periocular triamcinolone acetonide in 4 patients (20%). After a mean follow-up of 24 months, mean BCVA was 20/200 (range, 20/2000-20/20). It was equal to or less than 20/200 in 20% of eyes. Complications in the sympathizing eye included cataract in 5 eyes (25%), glaucoma in 4 eyes (20%), cystoid macular edema in 4 eyes (20%), and choroidal neovascularization in one eye (5%).
Conlusions
Sympathetic ophthalmia is a rare, but sight-threatening condition. It is related to vitreoretinal surgery in one fifth of cases. Diagnosis is based on suggestive clinical manifestations and typical multimodal imaging findings in patients with a history of ocular trauma or surgery. Management usually requires corticosteroids and immunosuppressive therapy. Complications may occur and are associated with worse visual prognosis.
Financial Disclosure
No financial interest for all authors
Comments
-